- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Theses and Dissertations /
- Modulation of the immune system by Listeria monocytogenes
Open Collections
UBC Theses and Dissertations
UBC Theses and Dissertations
Modulation of the immune system by Listeria monocytogenes Aloyouni, Sheka Yagub
Abstract
We had previously shown that attenuated Listeria monocytogenes (Lm) vaccines induce a strong Th1 response in neonatal mice, and prophylactically protect against histopathological signs of asthma. To test the ability of Lm as a therapeutic vaccine to diminish allergic sensitization in a mouse model of ovalbumin (OVA)-induced asthma, adult mice were sensitized intraperitoneally and challenged intranasally with OVA to induce asthma. Mice were then immunized intraperitoneally with a single dose of either live attenuated Lm vaccine that expresses OVA (LmOVA), live Lm expressing no allergen, or NaCl. Six weeks later, anesthetized mice were challenged intranasally with OVA and evaluated for cellular infiltration and tissue remodeling. We found that vaccination with live-attenuated Lm strains did not reduce already established allergic inflammation in all of the parameters we measured except that it did significantly reduce the total BALF eosinophil count in the LmOVA group. To test the functional impact of our prophylactic vaccine approach in vivo, we immunized mice as newborns with live LmOVA or Lm, followed 6 weeks later by allergic sensitization with OVA and evaluation by FlexiVent to determine airway hyperreactivity. We found that prophylactic vaccination reduced airway hyperreactivity, in an antigen-specific (i.e. LmOVA) as well as non-specific (i.e. Lm not expressing OVA) manner. Thus, our neonatal prophylactic vaccine approach holds promise as a powerful tool to modulate early life immune ontogeny and effectively prevent asthma. In order to study any potentially harmful effect of neonatal immunization with Lm, newborn mice were immunized intraperitoneally with the live Lm attenuated strain or with saline. Six weeks later, anesthetized mice were challenged intranasally with Saccharopolyspora rectivirgula antigen (SR-Ag) on three consecutive days per week for three weeks. We were unable to detect any changes on the HP phenotype comparing vaccinate vs. unvaccinated mice. In conclusion, prophylactic neonatal immunization with Lm-based vaccines provided functional protection from asthma in vivo, and may also provide some therapeutic benefit. Importantly, Lm-induced early life immune modulation did not exacerbate the development of some Th1/Th17-biased diseases later in life.
Item Metadata
Title |
Modulation of the immune system by Listeria monocytogenes
|
Creator | |
Publisher |
University of British Columbia
|
Date Issued |
2013
|
Description |
We had previously shown that attenuated Listeria monocytogenes (Lm) vaccines induce a strong Th1 response in neonatal mice, and prophylactically protect against histopathological signs of asthma.
To test the ability of Lm as a therapeutic vaccine to diminish allergic sensitization in a mouse model of ovalbumin (OVA)-induced asthma, adult mice were sensitized intraperitoneally and challenged intranasally with OVA to induce asthma. Mice were then immunized intraperitoneally with a single dose of either live attenuated Lm vaccine that expresses OVA (LmOVA), live Lm expressing no allergen, or NaCl. Six weeks later, anesthetized mice were challenged intranasally with OVA and evaluated for cellular infiltration and tissue remodeling. We found that vaccination with live-attenuated Lm strains did not reduce already established allergic inflammation in all of the parameters we measured except that it did significantly reduce the total BALF eosinophil count in the LmOVA group.
To test the functional impact of our prophylactic vaccine approach in vivo, we immunized mice as newborns with live LmOVA or Lm, followed 6 weeks later by allergic sensitization with OVA and evaluation by FlexiVent to determine airway hyperreactivity. We found that prophylactic vaccination reduced airway hyperreactivity, in an antigen-specific (i.e. LmOVA) as well as non-specific (i.e. Lm not expressing OVA) manner. Thus, our neonatal prophylactic vaccine approach holds promise as a powerful tool to modulate early life immune ontogeny and effectively prevent asthma.
In order to study any potentially harmful effect of neonatal immunization with Lm, newborn mice were immunized intraperitoneally with the live Lm attenuated strain or with saline. Six weeks later, anesthetized mice were challenged intranasally with Saccharopolyspora rectivirgula antigen (SR-Ag) on three consecutive days per week for three weeks. We were unable to detect any changes on the HP phenotype comparing vaccinate vs. unvaccinated mice.
In conclusion, prophylactic neonatal immunization with Lm-based vaccines provided functional protection from asthma in vivo, and may also provide some therapeutic benefit. Importantly, Lm-induced early life immune modulation did not exacerbate the development of some Th1/Th17-biased diseases later in life.
|
Genre | |
Type | |
Language |
eng
|
Date Available |
2013-05-01
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
Attribution-NoDerivs 3.0 Unported
|
DOI |
10.14288/1.0071910
|
URI | |
Degree | |
Program | |
Affiliation | |
Degree Grantor |
University of British Columbia
|
Graduation Date |
2013-05
|
Campus | |
Scholarly Level |
Graduate
|
Rights URI | |
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution-NoDerivs 3.0 Unported